风湿免疫指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫指南

S2k 指南：皮肤红斑狼疮的诊断和治疗 - 第 2 部分：治疗、危险因素和其他专题

2021-08-02 德国皮肤病学会 JDDG

红斑狼疮皮肤型红斑狼疮皮肤疾病

皮肤红斑狼疮 (CLE) 是一种罕见的炎症性自身免疫性皮肤病，临床表现异质。目前，没有专门批准用于这种疾病的治疗方法。局部和全身药物在标签外使用。

中文标题：

S2k 指南：皮肤红斑狼疮的诊断和治疗 - 第 2 部分：治疗、危险因素和其他专题

英文标题：

S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics

发布机构：

德国皮肤病学会

发布日期：

2021-08-02

简要介绍：

皮肤红斑狼疮 (CLE) 是一种罕见的炎症性自身免疫性皮肤病，临床表现异质。目前，没有专门批准用于这种疾病的治疗方法。局部和全身药物在标签外使用。本指南的目标是根据 2009 年起的现有德国 S1 指南和欧洲 S2K 指南，就 CLE 患者的诊断和治疗提供基于共识的建议，siehe Kommentar。

相关资料下载：
[AttachmentFileName(sort=1, fileName=S2k 指南：皮肤红斑狼疮的诊断和治疗 - 第 2 部分：治疗、危险因素和其他专题.pdf)] GetToolGuiderByIdResponse(projectId=1, id=177901c00232a982, title=S2k 指南：皮肤红斑狼疮的诊断和治疗 - 第 2 部分：治疗、危险因素和其他专题, enTitle=S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics, guiderFrom=JDDG, authorId=0, author=, summary=皮肤红斑狼疮 (CLE) 是一种罕见的炎症性自身免疫性皮肤病，临床表现异质。目前，没有专门批准用于这种疾病的治疗方法。局部和全身药物在标签外使用。, cover=https://img.medsci.cn/2022118/1642439140488_5579292.jpg, journalId=0, articlesId=null, associationId=2255, associationName=德国皮肤病学会 , associationIntro=德国皮肤病学会 (DDG), copyright=0, guiderPublishedTime=Mon Aug 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #1c1d1e;">皮肤红斑狼疮 (CLE) 是一种罕见的炎症性自身免疫性皮肤病，临床表现异质。目前，没有专门批准用于这种疾病的治疗方法。局部和全身药物在标签外使用。本指南的目标是根据 2009 年起的现有德国 S1 指南</span><span style="color: #1c1d1e;">和欧洲 S2K 指南</span><span style="color: #1c1d1e;">，就 CLE 患者的诊断和治疗提供基于共识的建议，siehe Kommentar。</span></p>, tagList=[TagDto(tagId=5982, tagName=红斑狼疮), TagDto(tagId=6969, tagName=皮肤型红斑狼疮), TagDto(tagId=27230, tagName=皮肤疾病)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21023, categoryName=赛诺菲-赛能, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8270, appHits=134, showAppHits=0, pcHits=370, showPcHits=8134, likes=1, shares=26, comments=12, approvalStatus=1, publishedTime=Tue Jan 18 01:02:41 CST 2022, publishedTimeString=2021-08-02, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Jan 18 01:05:20 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 13:20:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=S2k 指南：皮肤红斑狼疮的诊断和治疗 - 第 2 部分：治疗、危险因素和其他专题.pdf)])
S2k 指南：皮肤红斑狼疮的诊断和治疗 - 第 2 部分：治疗、危险因素和其他专题.pdf
下载请点击：
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2096475, encodeId=c0eb20964e5db, content=学习学习，多积累临床经验, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2396454598, createdName=ms5000001846878537, createdTime=Thu Oct 27 15:32:13 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203635, encodeId=7af3120363594, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e305452776, createdName=ms2000000991580947, createdTime=Thu Mar 17 22:53:45 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191977, encodeId=22eb11919e7c7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e66497821, createdName=ms1000001612249930, createdTime=Thu Feb 10 19:38:28 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186124, encodeId=c2041186124f3, content=我也想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3782623532, createdName=863145837, createdTime=Wed Jan 19 19:26:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185708, encodeId=a3511185e082c, content=好好学习，天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Tue Jan 18 19:23:20 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-10-27 ms5000001846878537

    学习学习，多积累临床经验

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2096475, encodeId=c0eb20964e5db, content=学习学习，多积累临床经验, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2396454598, createdName=ms5000001846878537, createdTime=Thu Oct 27 15:32:13 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203635, encodeId=7af3120363594, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e305452776, createdName=ms2000000991580947, createdTime=Thu Mar 17 22:53:45 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191977, encodeId=22eb11919e7c7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e66497821, createdName=ms1000001612249930, createdTime=Thu Feb 10 19:38:28 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186124, encodeId=c2041186124f3, content=我也想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3782623532, createdName=863145837, createdTime=Wed Jan 19 19:26:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185708, encodeId=a3511185e082c, content=好好学习，天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Tue Jan 18 19:23:20 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-03-17 ms2000000991580947

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2096475, encodeId=c0eb20964e5db, content=学习学习，多积累临床经验, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2396454598, createdName=ms5000001846878537, createdTime=Thu Oct 27 15:32:13 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203635, encodeId=7af3120363594, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e305452776, createdName=ms2000000991580947, createdTime=Thu Mar 17 22:53:45 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191977, encodeId=22eb11919e7c7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e66497821, createdName=ms1000001612249930, createdTime=Thu Feb 10 19:38:28 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186124, encodeId=c2041186124f3, content=我也想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3782623532, createdName=863145837, createdTime=Wed Jan 19 19:26:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185708, encodeId=a3511185e082c, content=好好学习，天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Tue Jan 18 19:23:20 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-02-10 ms1000001612249930

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2096475, encodeId=c0eb20964e5db, content=学习学习，多积累临床经验, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2396454598, createdName=ms5000001846878537, createdTime=Thu Oct 27 15:32:13 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203635, encodeId=7af3120363594, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e305452776, createdName=ms2000000991580947, createdTime=Thu Mar 17 22:53:45 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191977, encodeId=22eb11919e7c7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e66497821, createdName=ms1000001612249930, createdTime=Thu Feb 10 19:38:28 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186124, encodeId=c2041186124f3, content=我也想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3782623532, createdName=863145837, createdTime=Wed Jan 19 19:26:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185708, encodeId=a3511185e082c, content=好好学习，天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Tue Jan 18 19:23:20 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-01-19 863145837

    我也想看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2096475, encodeId=c0eb20964e5db, content=学习学习，多积累临床经验, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f2396454598, createdName=ms5000001846878537, createdTime=Thu Oct 27 15:32:13 CST 2022, time=2022-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203635, encodeId=7af3120363594, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e305452776, createdName=ms2000000991580947, createdTime=Thu Mar 17 22:53:45 CST 2022, time=2022-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1191977, encodeId=22eb11919e7c7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50e66497821, createdName=ms1000001612249930, createdTime=Thu Feb 10 19:38:28 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186124, encodeId=c2041186124f3, content=我也想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f3782623532, createdName=863145837, createdTime=Wed Jan 19 19:26:15 CST 2022, time=2022-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185708, encodeId=a3511185e082c, content=好好学习，天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3e495565045, createdName=王江军, createdTime=Tue Jan 18 19:23:20 CST 2022, time=2022-01-18, status=1, ipAttribution=)]
    2022-01-18 王江军

    好好学习，天天向上

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2021 S2k 指南：皮肤红斑狼疮的诊断和治疗 - 第 1 部分：分类、诊断、预防、活动评分

德国皮肤病学会 (DDG) · 2021-08-13

2021 BAD指南：皮肤红斑狼疮患者的管理

英国皮肤科医师协会(BAD,British Association of Dermatologists) · 2021-06-25

2021 ADA/AADV/CSD指南：皮肤红斑狼疮的诊断，治疗和长期管理

暂未更新 · 2021-08-04